Lineage Cell Therapeutics
LCTX | AMEX
$0.80
-$0.11 (-12.53%)
At close: Nov 16, 2026, 4:00 PM ET
$0.86
+$0.06 (+7.50%)
After-hours:
Nov 16, 2026, 7:48 PM ET
Lineage Cell Therapeutics Employees
Company profile explainedEmployees
77
Change (1Y)
0
Growth (1Y)
0.00%
Revenue / Employee
$144,480
Profits / Employee
$23,373
Market Cap
$201.12M
Employees History
| Date | Employees | Change | % Change |
|---|---|---|---|
| Dec 31, 2025 | 77 | 0 | 0.00% |
| Dec 31, 2024 | 77 | 2 | +2.67% |
| Dec 31, 2023 | 75 | -3 | -3.85% |
| Dec 31, 2022 | 78 | 17 | +27.87% |
| Dec 31, 2021 | 61 | 6 | +10.91% |
| Dec 31, 2020 | 55 | 0 | 0.00% |
| Dec 31, 2019 | 55 | -24 | -30.38% |
| Dec 31, 2018 | 79 | -16 | -16.84% |
| Dec 31, 2017 | 95 | -7 | -6.86% |
| Dec 31, 2016 | 102 | 69 | +209.09% |
| Dec 31, 2015 | 33 | -84 | -71.79% |
| Dec 31, 2014 | 117 | 11 | +10.38% |
| Dec 31, 2013 | 106 | 33 | +45.21% |
| Dec 31, 2012 | 73 | 14 | +23.73% |
| Dec 31, 2011 | 59 | 28 | +90.32% |
| Dec 31, 2010 | 31 | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove LCTX